Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) FCF Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed FCF Margin for 16 consecutive years, with 12.58% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 2626.0% to 12.58% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.89%, a 1906.0% increase, with the full-year FY2024 number at 13.65%, down 164.0% from a year prior.
  • FCF Margin was 12.58% for Q3 2025 at Xtant Medical Holdings, up from 2.57% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 12.58% in Q3 2025 to a low of 23.42% in Q1 2024.
  • A 5-year average of 8.14% and a median of 11.49% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -1643bps in 2022, then skyrocketed 2626bps in 2025.
  • Xtant Medical Holdings' FCF Margin stood at 1.46% in 2021, then tumbled by -1126bps to 17.88% in 2022, then surged by 75bps to 4.55% in 2023, then surged by 100bps to 0.02% in 2024, then skyrocketed by 56713bps to 12.58% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's FCF Margin are 12.58% (Q3 2025), 2.57% (Q2 2025), and 0.26% (Q1 2025).